J. Safra Sarasin Holding Ag Cytokinetics Inc Transaction History
J. Safra Sarasin Holding Ag
- $5.52 Trillion
- Q1 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Cytokinetics Inc stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 27,791 shares of CYTK stock, worth $901,262. This represents 0.02% of its overall portfolio holdings.
Number of Shares
27,791
Previous 13,027
113.33%
Holding current value
$901,262
Previous $613 Million
82.27%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$476 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$384 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$323 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$259 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$197 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.05B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...